Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
- PMID: 10802716
- DOI: 10.1038/75063
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
Abstract
As acute hepatitis C virus (HCV) infection is clinically inapparent in most cases, the immunologic correlates of recovery are not well defined. The cellular immune response is thought to contribute to the elimination of HCV-infected cells and a strong HCV-specific T-helper-cell (Th) response is associated with recovery from acute hepatitis C (ref. 2). However, diagnosis of resolved hepatitis C is based at present on the detection of HCV-specific antibodies and the absence of detectable HCV RNA, and detailed comparison of the humoral and cellular immune response has been hampered by the fact that patient cohorts as well as HCV strains are usually heterogeneous and that clinical data from acute-phase and long-term follow-up after infection generally are not available. We studied a cohort of women accidentally exposed to the same HCV strain of known sequence and found that circulating HCV-specific antibodies were undetectable in many patients 18-20 years after recovery, whereas HCV-specific helper and cytotoxic T-cell responses with an interferon (IFN)-gamma-producing (Tc1) phenotype persisted. The data indicate these HCV-specific CD4 + and CD8+ T cells are biomarkers for a prior HCV exposure and recovery. Because of undetectable antibodies against HCV, the incidence of self-limited HCV infections and recovery may be underestimated in the general population.
Similar articles
-
Long-term follow-up after successful interferon therapy of acute hepatitis C.Hepatology. 2004 Jul;40(1):98-107. doi: 10.1002/hep.20291. Hepatology. 2004. PMID: 15239091
-
Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.J Med Virol. 2006 Sep;78(9):1190-7. doi: 10.1002/jmv.20680. J Med Virol. 2006. PMID: 16847959
-
Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.Hepatology. 2001 Jan;33(1):267-76. doi: 10.1053/jhep.2001.21162. Hepatology. 2001. PMID: 11124845
-
Pathogenesis of chronic hepatitis C virus infection.Antivir Ther. 1998;3(Suppl 3):25-35. Antivir Ther. 1998. PMID: 10726053 Review.
-
Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.Semin Liver Dis. 2007 May;27(2):152-60. doi: 10.1055/s-2007-979468. Semin Liver Dis. 2007. PMID: 17520515 Review.
Cited by
-
Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infection.Hepatol Int. 2012 Jan;6(1):350-5. doi: 10.1007/s12072-011-9321-8. Epub 2011 Nov 30. Hepatol Int. 2012. PMID: 26201340
-
The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.Gastroenterology. 2013 Nov;145(5):1026-34. doi: 10.1053/j.gastro.2013.07.044. Epub 2013 Jul 31. Gastroenterology. 2013. PMID: 23916846 Free PMC article.
-
Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.Med Microbiol Immunol. 2007 Sep;196(3):157-64. doi: 10.1007/s00430-007-0038-1. Epub 2007 Feb 16. Med Microbiol Immunol. 2007. PMID: 17574493
-
Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sites.J Virol. 2001 Dec;75(24):12088-97. doi: 10.1128/JVI.75.24.12088-12097.2001. J Virol. 2001. PMID: 11711599 Free PMC article.
-
Cellular immune selection with hepatitis C virus persistence in humans.J Exp Med. 2005 Jun 6;201(11):1741-52. doi: 10.1084/jem.20050121. J Exp Med. 2005. PMID: 15939790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials